最新研究顯示，新冠疫苗突破性感染不會影響愛滋病毒（HIV）的免疫狀態
New Study Shows COVID-19 Breakthroughs Don't Affect HIV Immune Status
Updated at: June 15, 2026 at 12:45 AM
一項來自CIVET-II隊列的最新研究，為愛滋病病毒感染者(PWH)帶來了令人放心的消息。
A recent study from the CIVET-II cohort brings reassuring news for people living with HIV (PWH).
研究人員評估了COVID-19突破性感染如何影響已接種疫苗者的CD4 T細胞計數，這是衡量免疫健康的一項關鍵指標。
Researchers evaluated how COVID-19 breakthrough infections affect CD4 T-cell counts—a key indicator of immune health—in vaccinated individuals.
研究結果顯示，雖然突破性感染仍可能發生，但並不會導致CD4細胞計數出現長期或臨床上顯著的下降。
The findings indicate that while breakthrough infections can occur, they do not lead to a long-term or clinically significant decline in CD4 counts.
儘管感染後可能會立即出現輕微的波動，但數據顯示免疫細胞會在兩個月內穩定反彈，證實了免疫系統的復原能力。
Although minor fluctuations may happen immediately after infection, data shows a consistent rebound in immune cells within two months, confirming the immune system's ability to recover.
然而，這項研究也強調了持續保持臨床謹慎的重要性。
However, this study also highlights the importance of ongoing clinical caution.
研究一致表明，與一般人群相比，愛滋病病毒感染者更容易感染突破性COVID-19。
Research consistently shows that individuals with HIV are more susceptible to contracting breakthrough COVID-19 infections than the general population.
此外，CD4計數較低者若受到感染，面臨重症的風險更高。
Furthermore, those with lower CD4 counts face a higher risk of severe illness if infected.
因此，醫學專家持續強調，雖然病毒可能不會永久損害接受治療患者的免疫狀態，但疫苗接種仍然是最關鍵的防禦手段。
Therefore, medical experts continue to emphasize that, while the virus may not permanently damage the immune status of treated patients, vaccination remains the most critical defense.
對愛滋病病毒感染者而言，及時接種疫苗對於預防重症和住院至關重要，在感染風險增加的現實與現代醫療介入已證實的功效之間取得平衡。
Staying up-to-date with vaccine doses is essential for PWH to prevent severe disease and hospitalization, balancing the reality of increased infection risk with the proven efficacy of modern medical interventions.
